Update on neurological paraneoplastic syndromes

Area of Science:

• Neurology
• Oncology
• Immunology

Background:

• Paraneoplastic neurologic syndromes (PNS) are a group of disorders triggered by an underlying cancer.
• They can manifest as isolated syndromes (e.g., cerebellar degeneration, limbic encephalitis) or complex phenotypes affecting multiple neurological levels.

Purpose of the Study:

• To provide an updated overview of paraneoplastic neurologic syndromes.
• To discuss associated tumors and the immune responses involved.
• To highlight recent therapeutic advancements.

Main Methods:

• Review of current literature on paraneoplastic neurologic syndromes.
• Analysis of diagnostic approaches, including antibody detection.
• Evaluation of treatment strategies and their efficacy.

Main Results:

• PNS exhibit diverse clinical presentations, from localized to widespread neurological deficits.
• Detection of specific antineuronal antibodies aids in diagnosis and cancer identification.
• Certain antibody-associated PNS demonstrate significant responsiveness to tumor-directed therapies and immunotherapy.

Conclusions:

• Recognizing PNS is crucial for early malignancy detection and timely treatment initiation.
• Prompt therapy offers the best chance to stabilize or improve neurological deficits.
• Syndromes associated with cell surface antibodies often lead to substantial recovery.